Abstract:Background: The spread of artemisinin-resistant Plasmodium falciparum is a global health concern. Myanmar stands at the frontier of artemisinin-resistant P. falciparum. Myanmar also has the highest reported malaria burden in Southeast Asia; it is integral in the World Health Organization's plan to eliminate malaria in Southeast Asia, yet few epidemiological data exist for the general population in Myanmar.Methods: This cross-sectional, probability household survey was conducted in Phyu township, Bago Region (central Myanmar), during the wet season of 2013. Interviewers collected clinical and behavioural data, recorded tympanic temperature and obtained dried blood spots for malaria PCR and serology. Plasmodium falciparum positive samples were tested for genetic mutations in the K13 region that may confer artemisinin resistance. Estimated type-specific malaria PCR prevalence and seroprevalence were calculated, with regression analysis to identify risk factors for seropositivity to P. falciparum. Data were weighted to account for unequal selection probabilities.Results: 1638 participants were sampled (500 households). Weighted PCR prevalence was low (n = 41, 2.5%) and most cases were afebrile (93%). Plasmodium falciparum was the most common species (n = 19. 1.1%) and five (26%) P. falciparum samples harboured K13 mutations. Plasmodium knowlesi was detected in 1.0% (n = 16) and Plasmodium vivax was detected in 0.4% (n = 7). Seroprevalence was 9.4% for P. falciparum and 3.1% for P. vivax. Seroconversion to P. falciparum was 0.003/year in the whole population, but 16-fold higher in men over 23 years old (LR test p = 0.016).Discussion: This is the first population-based seroprevalence study from central Myanmar. Low overall prevalence was discovered. However, these data suggest endemic transmission continues, probably associated with behavioural risk factors amongst working-age men. Genetic mutations associated with P. falciparum artemisinin resistance, the presence of P. knowlesi and discrete demographic risk groups present opportunities and challenges for malaria control. Responses targeted to working-age men, capable of detecting sub-clinical infections, and considering all species will facilitate malaria elimination in this setting.

The global distribution of clinical episodes of Plasmodium falciparum malaria

A world malaria map: Plasmodium falciparum endemicity in 2007

Estimating the global clinical burden of Plasmodium falciparum malaria in 2007

The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide

Mapping the global extent of malaria in 2005

A new world malaria map: Plasmodium falciparum endemicity in 2010

Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study

Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000-17: a spatial and temporal modelling study

Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods

Spatial and Space–time Distribution of Plasmodium Vivax and Plasmodium Falciparum Malaria in China, 2005–2014

Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015

A long neglected world malaria map: Plasmodium vivax endemicity in 2010

The international limits and population at risk of Plasmodium vivax transmission in 2009

The global distribution and population at risk of malaria: past, present, and future

Trends of the global, regional and national incidence of malaria in 204 countries from 1990 to 2019 and implications for malaria prevention

Spatial and Temporal Distribution of Falciparum Malaria in China

Malaria Epidemiology in Central Myanmar: Identification of a Multi-Species Asymptomatic Reservoir of Infection

Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study

The risks of malaria infection in Kenya in 2009